Navigation Links
Craneware Reports Six Monthly Financial Results
Date:2/22/2010

ATLANTA, Feb. 22 /PRNewswire/ -- Craneware plc (AIM: CRW.L), the leader in automated revenue integrity solutions for the U.S. healthcare market, is pleased to announce its financial results for the first half of fiscal year 2010. The company reports its financials on a six-month basis.  

Financial Highlights for the six months ending 12/31/09 include: (all figures in US dollars)

  • Total of $25.0m of contracts signed in the half (H109: $21.8m)
    • 25% increase in revenues to $13.3m (H109: $10.6m)
    • Future revenues under contract increasing to $71.8m (FY09: $60.1m).
  • EBITDA(1) increased 36% to $3.4m (H109: $2.5m).
  • EBITDA(1) margin increased to 26% (H109: 24%).
  • Profit before taxation increased by 28% to $3.3m (H109: $2.6m).
  • Basic EPS increased by 18% to $0.092 (H109: $0.078).
  • Interim dividend of 4.7 pence / 7.2 cents per share with total dividend for FY10 expected to be in line with stated progressive dividend policy. (FY09 Interim dividend 1.8 pence / 2.7 cents; FY09 total dividend 4.7 pence / 7.2 cents).

(1.)  EBITDA refers to earnings before interest, tax, depreciation, amortization and share based payments

Operational Highlights First Half of FY2010

  • Launched the Company's fifth product, Supplies ChargeLink™, and secured first sales
  • Increased product attachment rate to 1.5 (compared to 1.4 in FY09)
  • Signed reseller agreement with McKesson and secured first sales
  • Signed a multi-year contract with North Shore-LIJ Health System, the largest integrated healthcare system in New York State.

"Due to current legislative and fiscal pressures on healthcare providers, our customers are focusing on revenue integrity, a niche in the U.S. IT healthcare market, of which we are at the forefront," said Keith Neilson, CEO of Craneware. "These market dynamics combined with Craneware's focus on quality software and customer support have led to another record half of sales. With our sixth product due to launch this calendar year and our ongoing focus on sales execution, we are confident in our ability to achieve significant revenue and earnings growth."

A full copy of the Company's Half-Yearly Results can be found on Craneware's Web site at craneware.com. In the Investors area of the Web site, click on Announcements.

About Craneware

Craneware (AIM: CRW.L) is the leader in automated revenue integrity solutions that improve financial performance for healthcare organizations. Craneware's market-driven, SaaS solutions help hospitals and other healthcare providers more effectively price, charge and code for services and supplies associated with patient care. This optimizes reimbursement, increases operational efficiency and minimizes compliance risk. By partnering with Craneware, clients achieve the visibility required to identify, address and prevent revenue leakage. To learn more, visit craneware.com.

SOURCE Craneware, Inc.

Back to top

RELATED LINKS
http://www.craneware.com

'/>"/>

SOURCE Craneware, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Cranewares Chargemaster Toolkit(R) Earns #1 KLAS Rank for Fourth Consecutive Year
2. Craneware Announces Fiscal Year-End Results
3. Craneware to Highlight Best Practices for Optimizing Revenue Capture Processes in Two Seminar Presentations during HFMAs 2009 ANI: The Healthcare Finance Conference
4. Craneware Supports Hospitals Compliance and Upfront Collections with Accurate Estimates
5. Craneware Appoints New Non-Executive Director
6. Craneware to Offer Financial Performance Solutions to Hospitals and Healthcare Providers Through Premier, the Largest U.S. Healthcare Alliance
7. Craneware and St. Joseph to Present Revenue Enhancement Success Story at HIMSS
8. Craneware Announces Half-Year Results
9. Remove Diabetes Drug Avandia From Market: FDA Reports
10. GSI Group Reports Preliminary Fourth Quarter 2009 Bookings, and Cash Balance
11. NIH Stem Cell Guidelines Should Be Modified, UCSF Team Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... While it’s often important to take certain medications ... from Austin, Texas, has identified a solution. , She developed a prototype for MOTION ... As such, it eliminates the need to turn on a light when taking medication ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Lori R. Somekh, ... member of ElderCounsel, a national organization of elder law and special needs planning attorneys. ... and rules. It also provides a forum to network with elder law attorneys nationwide,” ...
(Date:10/13/2017)... ... 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought ... This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at ... towards children of all ages; it is a non-competitive, non-timed event, which is all ...
(Date:10/13/2017)... ... 13, 2017 , ... “America On The Brink”: the Christian history of the ... is the creation of published author, William Nowers. Captain Nowers and his wife, ... he spent thirty years in the Navy. Following his career as a naval ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), ... of an innovative new design of the shoulder pad. The shoulder pad provides ... while controlling your pain while using cold therapy. By utilizing ice and water that ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host ... webcast on Friday, November 3, 2017, beginning at 7:00 ... approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... performance and guidance for 2018, Hill-Rom executives will also ... performance, and long-range financial outlook through 2020. ...
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
Breaking Medicine Technology: